Verismo Therapeutics Announces Upcoming Presentation at SITC 2023

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Verismo-Therapeutics

More Like This

XNK Therapeutics announces poster presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

BerGenBio Announces Poster Presentation at Upcoming SITC Meeting

T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Signaling Major Shift to Clinical Stage with DKK40M Financing Secured

ACCESS Newswire logo

PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference

Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023

Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial

Business Wire logo

Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

Merus Announces Abstract Accepted for Presentation at the ESMO Asia Congress 2024